Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
Author:
JL Mega,E Braunwald,S Mohanavelu,P Burton,R Poulter,F Misselwitz,V Hricak,ES Barnathan,P Bordes,A Witkowski,V Markov,L Oppenheimer,CM Gibson
Copyright © 2009 Elsevier Ltd. All rights reserved.